School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Pharmacoeconomics. 2011 Jun;29(6):475-95. doi: 10.2165/11586420-000000000-00000.
All healthcare systems routinely make resource allocation decisions that trade off potential health gains to different patient populations. However, when such trade-offs relate to the introduction of new, promising health technologies, perceived 'winners' and 'losers' are more apparent. In recent years, public scrutiny over such decisions has intensified, raising the need to better understand how they are currently made and how they might be improved. The objective of this paper is to critically review and compare current processes for making health technology funding decisions at the regional, state/provincial and national level in 20 countries. A comprehensive search for published, peer-reviewed and grey literature describing actual national, state/provincial and regional/institutional technology decision-making processes was conducted. Information was extracted by two independent reviewers and tabulated to facilitate qualitative comparative analyses. To identify strengths and weaknesses of processes identified, websites of corresponding organizations were searched for commissioned reviews/evaluations, which were subsequently analysed using standard qualitative methods. A total of 21 national, four provincial/state and six regional/institutional-level processes were found. Although information on each one varied, they could be grouped into four sequential categories: (i) identification of the decision problem; (ii) information inputs; (iii) elements of the decision-making process; and (iv) public accountability and decision implementation. While information requirements of all processes appeared substantial and decision-making factors comprehensive, the way in which they were utilized was often unclear, as were approaches used to incorporate social values or equity arguments into decisions. A comprehensive inventory of approaches to implementing the four main components of all technology funding decision-making processes was compiled, from which areas for future work or research aimed at improving the acceptability of decisions were identified. They include the explication of decision criteria and social values underpinning processes.
所有医疗保健系统都经常做出资源分配决策,以权衡不同患者群体的潜在健康收益。然而,当这些权衡涉及到引入新的、有前途的卫生技术时,所谓的“赢家”和“输家”就更加明显了。近年来,公众对这些决策的审查力度加大,因此需要更好地了解它们目前是如何做出的,以及如何改进。本文的目的是批判性地回顾和比较 20 个国家在地区、州/省和国家层面制定卫生技术资金决策的现行程序。对描述实际国家、州/省和地区/机构技术决策过程的已发表的同行评议和灰色文献进行了全面搜索。两名独立审查员提取信息并制表,以便进行定性比较分析。为了确定确定的过程的优缺点,搜索了相应组织的网站,以寻找委托的审查/评估,然后使用标准的定性方法对其进行分析。共发现 21 个国家、4 个省/州和 6 个地区/机构层面的流程。尽管每个流程的信息都有所不同,但它们可以分为四个连续的类别:(i)确定决策问题;(ii)信息投入;(iii)决策过程要素;和(iv)公共问责制和决策执行。虽然所有流程的信息要求似乎都很充足,决策因素也很全面,但它们的利用方式往往不明确,将社会价值观或公平论点纳入决策的方法也是如此。编制了所有技术资金决策制定流程的四个主要组成部分实施方法的综合清单,从中确定了旨在提高决策可接受性的未来工作或研究领域。它们包括阐明决策标准和过程背后的社会价值观。